menu

Tag: asco 2021 highlights

Takeda’s Flagship Product Panitumumab (PAN)+mFOLFOX6 Ve...

Takeda’s Flagship Product Panitumumab (PAN)+mFOLFOX6 Versus bevacizumab (BE...

  • havensmith

Daiichi’s novel HER3 ADC has Shown To Have a Spark in H...

Daiichi’s novel HER3 ADC has Shown To Have a Spark in HER3 NSCLC, post succ...

  • havensmith

Junshi’s domestic Toripalimab’s significant results in...

Junshi’s domestic Toripalimab’s significant results in recurrent or metasta...

  • havensmith